Skip to content

To Study Effect Of Ayurvedic drug in Management Of Vran with Reference To Lacerated Wound

A Randomised Controlled Clinical Trial To Study The Efficacy Of Manjisthadi Tail Local Application in The Management Of Kshataj Vran With Special Reference To Lacerated Wound - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079540
Enrollment
40
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T07- Unspecified multiple injuries

Interventions

None listed

Sponsors

Department of Shalyatantra Dr Vjd Gramin Ayurvedic Mahavidyalaya Patur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A)Patient having age between 20to 60 years. B) Patients irrespective of gender, economic class, caste, religion. C) Patient having sign and symptoms of kshataj vrana having area less then length 5 cmx 5cm& max depth: upto dermis(approx) be randomly selected.

Exclusion criteria

Exclusion criteria: A] Known cases of HIV, Hepatitis B, TB,any systemic disease like DM. B] Bleeding disorders C] Patient on aspiring and others anti platelets drug D]Tubercular Ulcers, venous ulcer, leprotic ulcer, malignant ulcer, Burns etc. E] Wounds having excessive loss of Tissues i.e.wound include bone, and tendon injury, exposed bone F] Patient suffering from chinn Vrana(excise wound) G] Bhinn Vrana(stab injury) H] Picchita Vrana(crushed injury) Vidhha Vrana(punctured wound) J] Complex wound like wound associated with fracture, ligament tear, tendon rupture, wound with profuse continuous bleedind which needs surgical haemostasis. K] All medico-legal cases Withdrawal Criteria – -If patient is not willing to continue the treatment -Patient unable to tolerate the treatment. -Any unknown adverse drug reaction of treatment on patient.Patient fails to report for follow up or irregular medication.

Design outcomes

Primary

MeasureTime frame
Decrease in SymptomsTimepoint: 15 days

Secondary

MeasureTime frame
Kshataj Vrana will be clearedTimepoint: 15 days

Countries

India

Contacts

Public ContactDr Gayatri Mawale

Dr.VJD Gramin Ayurved Mahavidyalaya

gayatriakola@gmail.com9850500860

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026